Hudson J B, Graham E A, Simpson M F
Division of Medical Microbiology, University of British Columbia, Vancouver, Canada.
Antiviral Res. 1988 Sep;9(6):379-85. doi: 10.1016/0166-3542(88)90039-3.
Various compounds, with known clinical efficacy against human viruses, were evaluated for their ability to inhibit the growth of infectious hematopoietic necrosis virus (IHNV, a rhabdovirus), and infectious pancreatic necrosis virus (IPNV, a birnavirus), in rainbow trout cell cultures. Amantadine inhibited the plaque forming ability of IHNV, at concentrations which did not affect cell growth or morphology, although it was not active against IPNV. Metisazone and bis-benzimidazole were also effective against IHNV; but they were slightly cytotoxic. Ribavirin, as expected, was active against IPNV, but was also equally effective against IHNV, although it was cytotoxic. Several other compounds were also tested but they were not inhibitory to either virus. The attraction of amantadine is the fact that relatively easy administration should be feasible.
在虹鳟鱼细胞培养物中,对多种已知对人类病毒有临床疗效的化合物进行了评估,以确定它们抑制传染性造血坏死病毒(IHNV,一种弹状病毒)和传染性胰腺坏死病毒(IPNV,一种双RNA病毒)生长的能力。金刚烷胺在不影响细胞生长或形态的浓度下,抑制了IHNV的蚀斑形成能力,尽管它对IPNV没有活性。甲吲噻腙和双苯并咪唑对IHNV也有效,但它们有轻微的细胞毒性。如预期的那样,利巴韦林对IPNV有活性,但对IHNV同样有效,尽管它有细胞毒性。还测试了其他几种化合物,但它们对这两种病毒均无抑制作用。金刚烷胺的吸引力在于,相对容易给药应该是可行的。